TriPath Withdraws Its Second PMA Supplement Application This Year
This article was originally published in The Gray Sheet
Executive Summary
TriPath Imaging has been reorganizing its clinical and regulatory affairs operations to prevent the continuation of problems that caused it to withdraw two separate PMA supplements so far this year